 Buprenorphine
"Buprenorphine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A derivative of the opioid alkaloid THEBAINE that is a more potent and longer lasting analgesic than MORPHINE. It appears to act as a partial agonist at mu and kappa opioid receptors and as an antagonist at delta receptors. The lack of delta-agonist activity has been suggested to account for the observation that buprenorphine tolerance may not develop with chronic use.
| Descriptor ID |
D002047
|
| MeSH Number(s) |
D03.132.577.249.150 D03.605.497.150 D03.633.400.686.150 D04.615.723.795.150
|
| Concept/Terms |
Subutex- Subutex
- Buprex
- Temgesic
- Temgésic
6029-M- 6029-M
- 6029 M
- 6029M
- RX-6029-M
- RX 6029 M
- RX6029M
|
Below are MeSH descriptors whose meaning is more general than "Buprenorphine".
Below are MeSH descriptors whose meaning is more specific than "Buprenorphine".
This graph shows the total number of publications written about "Buprenorphine" by people in this website by year, and whether "Buprenorphine" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 | | 2003 | 0 | 1 | 1 | | 2007 | 1 | 0 | 1 | | 2014 | 1 | 1 | 2 | | 2015 | 1 | 0 | 1 | | 2016 | 1 | 0 | 1 | | 2017 | 2 | 1 | 3 | | 2018 | 2 | 2 | 4 | | 2019 | 9 | 5 | 14 | | 2020 | 16 | 1 | 17 | | 2021 | 17 | 1 | 18 | | 2022 | 16 | 0 | 16 | | 2023 | 21 | 0 | 21 | | 2024 | 13 | 2 | 15 | | 2025 | 8 | 1 | 9 |
To return to the timeline, click here.
Below are the most recent publications written about "Buprenorphine" by people in Profiles.
-
Ostrowski SJ, Adkins A, Goldfarb D, Kukowski M, Stratton D, Barton DJ, Pizon AF. Transdermal buprenorphine patch-facilitated induction of sublingual buprenorphine in hospitalized patients receiving full agonist opioids: a retrospective cohort study. Clin Toxicol (Phila). 2025 Nov; 63(11):897-905.
-
Haskins C, Amspoker AB, Walder A, Hogan J, Ecker A, Lindsay J, Shore J. Telehealth Buprenorphine Initiation for Opioid Use Disorder Among American Indian and Alaska Native Veterans, April 2017-March 2023. Telemed J E Health. 2025 Nov; 31(11):1333-1341.
-
Shastry S, Carpenter J, Krotulski A, Brent J, Wax P, Aldy K, Campleman S, Culbreth R, Falise A, Hughes A, Hendrickson RG, Amaducci A, Judge B, Meaden C, Calello DP, Buchanan J, Shulman J, Levine M, Schwarz E, Manini AF. Disparities in Treatment and Referral After an Opioid Overdose Among Emergency Department Patients. JAMA Netw Open. 2025 07 01; 8(7):e2518569.
-
Haber LA, Berk J, Taub J, South AM. Initiating Medications for Opioid Use Disorder in Hospitalized Incarcerated Patients. J Gen Intern Med. 2025 Nov; 40(14):3481-3485.
-
Becker WC, Seal KH, Nelson DB, DeRonne BM, Kats AM, Morasco BJ, Frank JW, Makris UE, Painter JT, Allen KD, Mixon AS, Bohnert A, Reznik TE, Hagedorn HJ, Hammett P, Borsari B, Baxley C, Krebs EE. Buprenorphine, Pain, and Opioid Use in Patients Taking High-Dose Long-Term Opioids: A Randomized Clinical Trial. JAMA Intern Med. 2025 Apr 01; 185(4):372-381.
-
Lebin JA, Sommers S, Lun Z, Hensen C, Hoppe JA. Clinical decision support as an implementation strategy to expand identification and administration of treatment of opioid use disorder in the emergency department. J Subst Use Addict Treat. 2025 May; 172:209653.
-
Iscoe MS, Diniz Hooper C, Levy DR, Buchanan L, Dziura J, Meeker D, Taylor RA, D'Onofrio G, Oladele C, Sarpong DF, Paek H, Wilson FP, Heagerty PJ, Delgado MK, Hoppe J, Melnick ER. Adaptive decision support for addiction treatment to implement initiation of buprenorphine for opioid use disorder in the emergency department: protocol for the ADAPT Multiphase Optimization Strategy trial. BMJ Open. 2025 Feb 20; 15(2):e098072.
-
Fine DR, Critchley N, Hart K, Regan S, Sporn N, Gaeta J, Wright J, Kruse G, Baggett TP. Buprenorphine adherence among a prospective cohort of homeless-experienced adults with opioid use disorder. Drug Alcohol Depend. 2025 May 01; 270:112598.
-
Hall TL, Mendez D, Sobczak C, Mathieu S, Wiggins K, Cebuhar K, Quintana L, Weiss J, Knierim K. Evaluation of a Program Designed to Support Implementation of Prescribing Medication for Treatment of Opioid Use Disorder in Primary Care Practices. Ann Fam Med. 2025 Jan 27; 23(1):44-51.
-
Tremonti C, Blogg J, Jamshidi N, Harjanto R, Miles N, Ismay C, Page R, Mills L, Buckley N, Perananthan V, Lintzeris N, Haber P. Methadone-Buprenorphine Transfers Using Low Dosing of Buprenorphine: An Open-label, Nonrandomized Clinical Trial. J Addict Med. 2025 Jan-Feb 01; 19(1):75-82.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|